Atossa Therapeutics, Inc.
(NASDAQ:ATOS)
$0.679
-0.04 (-5.14%)
At Close: 4:00 PM
$0.7
0.02 (3.05%)
After Market: 8:22 PM
ATOS Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
ATOS Stock Price Today
Atossa Therapeutics, Inc. (ATOS) stock declined over -5.14% intraday to trade at $0.6793 a share on NASDAQ. The stock opened with a loss of 0.00% at $0.716 and touched an intraday high of $0.734, falling -5.14% against the last close of $0.716. The Atossa Therapeutics, Inc. in stock market went to a low of $0.671 during the session.
ATOS Stock Snapshot
$0.716
Prev. Close
86.02 Million
Market Cap
$0.671
Day Low
$0.716
Open
126.62 Million
Number of Shares
$0.734
Day High
-
P/E ratio
-0.19
EPS (TTM)
0.93
Cash Flow per Share
6.75
Free Float in %
0.56
Book Value
322,096
Volume
Contact Details
107 Spring Street
Seattle, WA 98104
United States
Website:https://www.atossatherapeutics.com
Contact #:206 588 0256
Company Information
Employees4
Beta1.19
Sales or Revenue-
5Y Sales Change-
Fiscal Year EndsDec. 2021
SectorHealth Care
IndustryBiotechnology
About Company
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patients; AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; and immunotherapy/chimeric antigen receptor therapy programs for the treatment of breast cancer. It has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.
Frequently Asked Questions
What is the current Atossa Therapeutics, Inc. (ATOS) stock price?
Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock price is $0.68 in the last trading session. During the trading session, ATOS stock reached the peak price of $0.734 while $0.671 was the lowest point it dropped to. The percentage change in ATOS stock occurred in the recent session was -5.14% while the dollar amount for the price change in ATOS stock was -$0.04.
ATOS's industry and sector of operation?
The NASDAQ listed ATOS is part of Biotechnology industry that operates in the broader Health Care sector. Atossa Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases.
Who are the executives of ATOS?
Ms. Delly Behen P.H.R.
Vice President of Admin. & HR
Ms. Heather Rees
Vice President of Fin. & Accounting
Ms. Janet Rose Rea MSPH, RAC
Senior Vice President of Regulatory, Quality & Clinical Affairs
Mr. Kyle Guse CPA, Esq., CPA
Chief Financial Officer, Gen. Counsel & Sec.
How ATOS did perform over past 52-week?
ATOS's closing price is 0.36% higher than its 52-week low of $0.5 where as its distance from 52-week high of $1.54 is -0.56%.
How many employees does ATOS have?
Number of ATOS employees currently stands at 4. ATOS operates from 107 Spring Street, Seattle, WA 98104, United States.
Link for ATOS official website?
Official Website of ATOS is: https://www.atossatherapeutics.com
How do I contact ATOS?
ATOS could be contacted at phone #206 588 0256 and can also be accessed through its website. ATOS operates from 107 Spring Street, Seattle, WA 98104, United States.
How many shares of ATOS are traded daily?
ATOS stock volume for the day was 322,096 shares. The average number of ATOS shares traded daily for last 3 months was 511.66 Thousands.
What is the market cap of ATOS currently?
The market value of ATOS currently stands at $86.02 Million with its latest stock price at $0.68 and 126.62 Million of its shares outstanding.